(HealthDay)—The number of meningitis cases linked to apparently contaminated steroid injections has risen to 91 in nine states, and the number of deaths remains at seven, U.S. health officials reported Sunday.
Oct 8, 2012
0
0
(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.
Oct 5, 2012
0
0
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.
Oct 4, 2012
0
0
(HealthDay)—The risk of venous thromboembolism (VTE) in postmenopausal women differs considerably according to the formulation of hormone therapy (HT) used, with the highest VTE risk seen in users of oral estrogen-progestin ...
Sep 18, 2012
0
0
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer, ...
Sep 17, 2012
0
0
(HealthDay) -- Fluid resuscitation with hydroxyethyl starch (HES) 130/0.4 for patients with severe sepsis leads to an increased risk of death at day 90 and an increased likelihood of requiring renal-replacement therapy, compared ...
Jun 28, 2012
0
0
(HealthDay) -- For women taking hormonal contraceptives, sex hormone-binding globulin (SHBG) is a useful marker to estimate the risk of venous thrombosis, according to research published in the June issue of the Journal of ...
Jun 8, 2012
0
0
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients ...
Jun 2, 2012
0
0
A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.
Nov 22, 2011
0
0
The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with ...
Jun 6, 2011
0
0
